United States · FDA National Drug Code directory
Bupropion hydrochloride (XL)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69680-157_c7d45984-a653-4be6-9b1c-986a553e4e42
- Product NDC
- 69680-157
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion hydrochloride
- Labeler
- Vitruvias Therapeutics
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230410
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-30) · 69680-157-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-90) · 69680-157-90
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-92) · 69680-157-92
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-157-93) · 69680-157-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →